Transgene Stock

Transgene Interest Coverage

The Interest Coverage Ratio of Transgene (TNG.PA) as of Aug 10, 2026 is -77.18. In the previous year, Interest Coverage Ratio was -140.90 — a change of -45.23% (higher).

Interest Coverage

-77.18

YoY

-45.23%

Last updated:

Interest Coverage Ratio of Transgene is 2026 -77.18 . Interest Coverage Ratio of Transgene was 2025 -140.90 . It decreases by -45.23% higher compared to the previous year.
Access this data via the Eulerpool API

Transgene Stock analysis

What does Transgene do? Transgene SA is a French biotechnology company specializing in the development and production of therapeutics, with a focus on cancer medications. It has a strong patent portfolio in the field of viral vectors, which are used for targeted gene therapy. The company's main areas of operation are clinical trials, research, and production. Transgene has research and production facilities in Strasbourg and Lyon, with over 100 employees. It has established partnerships with pharmaceutical companies, including Takeda Pharmaceuticals, for the development and marketing of therapeutics. Its flagship product, OncoVir-1®, is an immunomodulator that stimulates the immune system to fight tumor cells. Another promising product is TG4010, a therapeutic vaccine for non-small cell lung carcinoma. Transgene is an emerging company with a promising portfolio of cancer therapeutics, leveraging its expertise in viral vectors and collaborating closely with industry partners to expedite the development of marketable products. Transgene is expected to play a significant role in the development of new and innovative cancer treatments. Transgene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Transgene stock

Interest Coverage Ratio of Transgene is -77.18 in 2026.

Interest Coverage Ratio of Transgene changed from -140.90 to -77.18, representing a -45.23% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Transgene since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Transgene with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Transgene

All Key Metrics — Transgene